Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
type: MedicalStudy
description: Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2005-08
end date: 2006-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00132496
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Eisai Inc.
study subject: Gastroesophageal Reflux Disease
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Gastroesophageal Reflux Disease

AI Analytics
type: Organization